Clinical Trial Update: A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate BMS-986278 in participants with normal renal function, severe renal impairment, or end-stage renal disease on intermittent hemodialysi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• BMS-986278

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Kidney Failure, Chronic, Healthy Volunteers | Phase 1 | Status: COMPLETED